Huahai Pharmaceutical's New Drug Valsartan Tablets Approved for Sale in the U.S.
-
Last Update: 2015-06-11
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Huahai pharmaceutical announced in the evening of June 11 that the company had received a notice from the U.S Food and Drug Administration (FDA) that the company had approved the Anda (American generic drug application) of valsartan tablets declared to the FDA, which means that the applicant can produce and sell the product in the U.S market) The original research company of valsartan tablets is Novartis (Novartis), which is used to treat essential hypertension The acquisition of the preparation number indicates that the company has the qualification to sell the product in the U.S market According to IMS data, the total sales volume of valsartan tablets in the U.S market in 2014 was USD 1522 million.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
